FLT3 and acute lymphoblastic leukemia: We explored the prevalence of FLT3-ITD mutation in a large series of pediatric ETP-ALL enrolled in three consecutive protocols of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and we evaluated the potential use of FLT3-ITD as an alternative DNA marker for MRD monitoring.